Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2393
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Intravitreal recombinant tissue plasminogen activator without and with additional gas injection in patients with submacular haemorrhage associated with age-related macular degeneration
Anna Tsymanava,Constantin E. Uhlig
Acta Ophthalmologica.2012;90(7)633
[DOI]
2Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration
Jan Janusz Sniatecki,Gregory Ho-Yen,Benjamin Clarke,Ramez Barbara,Stephen Lash,Thomas Papathomas,Serafeim Antonakis,Bhaskar Gupta
European Journal of Ophthalmology.2019;90(7)112067211989162
[DOI]
3Treatment Outcomes in Eyes with Polypoidal Choroidal Vasculopathy with Poor Baseline Visual Acuity
Jae Hui Kim,Jong Woo Kim,Tae Gon Lee,Young Ju Lew
Journal of Ocular Pharmacology and Therapeutics.2015;31(4)241
[DOI]
4Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage
Handan Bardak,Yavuz Bardak,Yesim Erçalik,Burak Erdem,Gökhan Arslan,Semrin Timlioglu
European Journal of Ophthalmology.2018;28(3)306
[DOI]
5Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature
Dinu Stanescu-Segall,Florian Balta,Timothy L. Jackson
Survey of Ophthalmology.2016;61(1)18
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal